Vigilant Capital Management, LLC Bristol Myers Squibb CO Transaction History

Vigilant Capital Management, LLC

$1.34 Billion
Q2 2023

A detailed history of Vigilant Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vigilant Capital Management, LLC holds 10,749 shares of BMY stock, worth $429,852. This represents 0.05% of its overall portfolio holdings.

Number of Shares

10,749

Previous 9,849 9.14%

Holding current value

$429,852

Previous $683,000 0.59%

% of portfolio

0.05%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $57,339 - $63,665	900 Added 9.14%	10,749 $687,000
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $29,569 - $33,538	450 Added 4.79%	9,849 $683,000
Q3 2022 Oct 25, 2022	SELL	$0.13 - $76.84 $23 - $13,908	-181 Reduced 1.89%	9,399 $668,000
Q2 2022 Jul 06, 2022	BUY	$72.62 - $79.98 $13,144 - $14,476	181 Added 1.93%	9,580 $738,000
Q4 2021 Jan 06, 2022	BUY	$53.63 - $62.52 $401,045 - $467,524	7,478 Added 389.28%	9,399 $586,000

Q3 2021 Oct 08, 2021	BUY	$59.17 - $69.31 $19,703 - $23,080	333 Added 20.97%	1,921 $114,000
Q2 2021 Jul 09, 2021	BUY	$61.91 - $67.42 $2,414 - $2,629	39 Added 2.52%	1,588 $106,000
Q1 2021 Apr 16, 2021	SELL	$59.34 - $66.74 $84,025 - $94,503	-1,416 Reduced 47.76%	1,549 $98,000
Q4 2020 Jan 14, 2021	SELL	$57.74 - $65.43 $19,285 - $21,853	-334 Reduced 10.12%	2,965 $184,000
Q3 2020 Oct 15, 2020	BUY	$57.43 - $63.64 $20,732 - $22,974	361 Added 12.29%	3,299 $199,000
Q1 2020 Apr 17, 2020	SELL	$46.4 - $67.43 $130,059 - $189,006	-2,803 Reduced 48.82%	2,938 $164,000
Q4 2019 Jan 17, 2020	SELL	$49.21 - $64.19 $14,615 - $19,064	-297 Reduced 4.92%	5,741 $369,000
Q2 2019 Jul 18, 2019	SELL	$44.62 - $49.34 $122,035 - $134,944	-2,735 Reduced 31.18%	6,038 $274,000
Q1 2019 Apr 09, 2019	SELL	$45.12 - $53.8 $60,460 - $72,092	-1,340 Reduced 13.25%	8,773 $419,000
Q4 2018 Jan 15, 2019	BUY	$48.76 - $63.23 $21,454 - $27,821	440 Added 4.55%	10,113 $526,000
Q3 2018 Oct 11, 2018	SELL	$55.19 - $62.25 $33,114 - $37,350	-600 Reduced 5.84%	9,673 $600,000
Q2 2018 Jul 11, 2018	SELL	$50.53 - $62.98 $81,100 - $101,082	-1,605 Reduced 13.51%	10,273 $569,000
Q1 2018 Apr 04, 2018	SELL	$59.92 - $68.98 $58,721 - $67,600	-980 Reduced 7.62%	11,878 $751,000
Q4 2017 Jan 31, 2018	BUY	$59.94 - $65.35 $215,424 - $234,867	3,594 Added 38.8%	12,858 $788,000
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $511,650 - $590,487	9,264	9,264 $590,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $85B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vigilant Capital Management, LLC with notifications on news.

Account

Vigilant Capital Management, LLC Bristol Myers Squibb CO Transaction History